VBI Vaccines Inc (VBIV)
0.6205
+0.02
(+3.43%)
USD |
NASDAQ |
May 07, 16:00
0.62
0.00 (0.00%)
After-Hours: 20:00
VBI Vaccines Enterprise Value: 44.73M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 44.73M |
| May 06, 2024 | 44.14M |
| May 03, 2024 | 43.86M |
| May 02, 2024 | 43.65M |
| May 01, 2024 | 43.28M |
| April 30, 2024 | 43.32M |
| April 29, 2024 | 43.12M |
| April 26, 2024 | 43.40M |
| April 25, 2024 | 44.13M |
| April 24, 2024 | 43.86M |
| April 23, 2024 | 44.39M |
| April 22, 2024 | 44.23M |
| April 19, 2024 | 45.10M |
| April 18, 2024 | 44.99M |
| April 17, 2024 | 44.40M |
| April 16, 2024 | 44.71M |
| April 15, 2024 | 43.50M |
| April 12, 2024 | 43.50M |
| April 11, 2024 | 44.07M |
| April 10, 2024 | 43.69M |
| April 09, 2024 | 44.27M |
| April 08, 2024 | 49.11M |
| April 05, 2024 | 44.07M |
| April 04, 2024 | 43.07M |
| April 03, 2024 | 45.08M |
| Date | Value |
|---|---|
| April 02, 2024 | 43.83M |
| April 01, 2024 | 41.87M |
| March 28, 2024 | 41.50M |
| March 27, 2024 | 40.96M |
| March 26, 2024 | 40.96M |
| March 25, 2024 | 40.84M |
| March 22, 2024 | 40.84M |
| March 21, 2024 | 40.60M |
| March 20, 2024 | 40.84M |
| March 19, 2024 | 40.53M |
| March 18, 2024 | 40.72M |
| March 15, 2024 | 40.50M |
| March 14, 2024 | 41.18M |
| March 13, 2024 | 41.20M |
| March 12, 2024 | 41.89M |
| March 11, 2024 | 41.44M |
| March 08, 2024 | 40.96M |
| March 07, 2024 | 41.07M |
| March 06, 2024 | 41.32M |
| March 05, 2024 | 40.99M |
| March 04, 2024 | 40.86M |
| March 01, 2024 | 41.20M |
| February 29, 2024 | 40.96M |
| February 28, 2024 | 40.49M |
| February 27, 2024 | 40.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
24.38M
Minimum
Jun 27 2023
1.352B
Maximum
Jul 17 2020
306.32M
Average
169.92M
Median
Jul 07 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.560M |
| Palatin Technologies Inc | 24.08M |
| iBio Inc | 16.84M |
| Theriva Biologics Inc | -13.05M |
| Oragenics Inc | 4.426M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.013M |
| Revenue (Quarterly) | 0.853M |
| Total Expenses (Quarterly) | 13.22M |
| EPS Diluted (Quarterly) | -0.0065 |
| Gross Profit Margin (Quarterly) | -245.0% |
| Profit Margin (Quarterly) | -1.52% |
| Earnings Yield | -1.52K% |
| Normalized Earnings Yield | -904.02 |